GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NKGen Biotech Inc (NAS:NKGN) » Definitions » Accumulated Depreciation

NKGen Biotech (NKGen Biotech) Accumulated Depreciation : $-4.06 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is NKGen Biotech Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

NKGen Biotech's quarterly accumulated depreciation increased from Sep. 2023 ($-3.54 Mil) to Dec. 2023 ($-3.83 Mil) and increased from Dec. 2023 ($-3.83 Mil) to Mar. 2024 ($-4.06 Mil).

NKGen Biotech's annual accumulated depreciation increased from Dec. 2021 ($-1.53 Mil) to Dec. 2022 ($-2.69 Mil) and increased from Dec. 2022 ($-2.69 Mil) to Dec. 2023 ($-3.83 Mil).

NKGen Biotech Accumulated Depreciation Historical Data

The historical data trend for NKGen Biotech's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NKGen Biotech Accumulated Depreciation Chart

NKGen Biotech Annual Data
Trend Dec21 Dec22 Dec23
Accumulated Depreciation
-1.53 -2.69 -3.83

NKGen Biotech Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Accumulated Depreciation Get a 7-Day Free Trial -2.69 - -3.54 -3.83 -4.06

NKGen Biotech Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

NKGen Biotech Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of NKGen Biotech's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

NKGen Biotech (NKGen Biotech) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NKGen Biotech Inc (NAS:NKGN) » Definitions » Accumulated Depreciation
Comparable Companies
OCUP CASI SPRO XLO NGM GBIO ASMB CCCC OCEA FIXX OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
19700 Fairchild Road, Suite No. 300, Irvine, CA, USA, 92612
Website
https://www.nkgenbiotech.com
NKGen Biotech Inc is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies utilizing our proprietary SNK (super-activated) platform.